FDA-Drug2025-12-31Class IIPROCESSING DEFECT
Merck Noxafil Powdermix (posaconazole) recalled for potential metal particulates
METALNationwide distribution
Stop using Merck Noxafil Powdermix immediately
Merck has recalled specific lots of Noxafil Powdermix, a prescription antifungal medication, because some packets may contain metal particles. This affects 845 kits distributed nationwide. No injuries have been reported.
- Check if you have Noxafil Powdermix lot Z012339, Z010344, Z009908, or Z009909 with expiration date 12-31-2026
- Do not use the product if you have one of these lots
- Contact your pharmacy or doctor for a replacement or alternative medication
- Return the recalled product to your pharmacy
Hazard
Presence of particulate matter: potential presence of metal particulates in the product.
Sold states
Nationwide in the USA
Affected count
845 kits
Manufactured in
4633 Merck Rd W, N/A, Wilson, NC, United States
Products
Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0242-2026Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief